International Journal of Pharmaceutics

Determination of baseline human nasal pH and the effect of intranasally administered buffers
pp. 139-146(8)
Authors: Washington N.; Steele R.J.C.; Jackson S.J.; Bush D.; Mason J.; Gill D.A.; Pitt K.; Rawlins D.A.

In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption
pp. 147-156(10)
Authors: Onuki Y.; Morishita M.; Takayama K.; Tokiwa S.; Chiba Y.; Isowa K.; Nagai T.

Effect of matrix composition and process conditions on casein-gelatin beads floating properties
pp. 157-165(9)
Authors: Bulgarelli E.; Forni F.; Bernabei M.T.

Structural relationship and desolvation behavior of cromolyn, cefazolin and fenoprofen sodium hydrates
pp. 167-177(11)
Authors: Stephenson G.A.; Diseroad B.A.

The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems
pp. 179-189(11)
Authors: El-Kattan A.F.; Asbill C.S.; Michniak B.B.

Effect of synthesized cyclohexanol derivatives using l-menthol as a lead compound on the percutaneous absorption of ketoprofen
pp. 191-200(10)
Authors: Obata Y.; Sato H.; Li C.J.; Takayama K.; Higashiyama K.; Nagai T.; Isowa K.

Wettability studies of morphine sulfate powders
pp. 201-212(12)
Authors: Prestidge C.A.; Tsatouhas G.

Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design
pp. 213-228(16)
Authors: Stensrud G.; Sande S.A.; Kristensen S.; Smistad G.

Membrane penetration enhancement of ibuprofen using supersaturation
pp. 229-238(10)
Authors: Iervolino M.; Raghavan S.L.; Hadgraft J.

Salt form selection and characterization of LY333531 mesylate monohydrate
pp. 239-247(9)
Authors: Engel G.L.; Farid N.A.; Faul M.M.; Richardson L.A.; Winneroski L.L.

Correspondence
pp. 249-250(2)
Authors: Newton J.M.; Podczeck F.

Correspondence
pp. 251-252(2)
Authors: Vachon M.G.; Chulia D.